article thumbnail

Challenges in the Medical Sales Industry

MedReps

Often we’re lucky if we even get to see our physicians, let alone overcome their objections regarding insurance coverage and competitive claims. Physician Access. Every year, another physician’s office or hospital system eliminates representative visits and lunches. Physician Apathy.

article thumbnail

Why Is FDA Issuing Fewer Marketing Violation Letters?

Pharma Marketing Network

Resource Constraints: The FDA operates within a dynamic regulatory environment and faces resource constraints like any other government agency. Limited staffing and budgetary challenges may impact the agency’s capacity to conduct thorough marketing compliance reviews and issue violation letters.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Traditional Pharma Model Isn’t Working – It’s Time to Evolve!

PharmaKinnex

“On April 18, 2002, the Pharmaceutical Research and Manufacturers of America (PhRMA) adopted a new marketing code to govern the pharmaceutical industry’s relationships with physicians and other health care professionals…” – AMA Journal of Ethics.

Pharma 52
article thumbnail

Data-Driven Connections: Linking Rare Disease Patients to Clinical Trials, Experts, and Resources

PM360

Once identified as likely , it’s much easier to engage a patient’s physician to conduct testing, refer to centers of excellence, or recommend clinical trial enrollment. It may be unreasonable to expect a doctor to remember the diagnostic criteria for each of 7,000+ rare diseases, but it’s quite reasonable to ask a machine to do that.

article thumbnail

What Is MedTech? With Chris Tremblay

Evolve Your Success

We allow the physicians and hospital systems on the backend to build in their own protocols for guidance. It’s work ethic, attitude, effort, consistency, and tenacity. Do you see this becoming mandated by the government that companies like yours need to be implemented in every healthcare institution sooner than later?

article thumbnail

Ep. 001 – John Mack Podcast Transcript

Pharma Marketing Network

I was at Physicians Online at the time. And I had experience doing these highlight bulletins when my work with RJ at the physicians’ online. They would write up the presentations by physicians about drugs. And then they were distributed to physicians’ online and the next day. You were PharmInfoNet. John Mack (PG): Right.

Media 52
article thumbnail

Preparing for stricter standards on substances of human origin

European Pharmaceutical Review

2 Having been in place for almost 20 years, the current legislation on blood and on tissues and cells is now outdated and does not reflect the health and societal evolutions These rules govern the sourcing and use of starting materials for innovative therapies, such as blood, tissues and cells.

Safety 62